These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 26930713)

  • 1. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
    Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
    Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-30c-regulated HDAC9 mediates chemoresistance of breast cancer.
    Liang Z; Feng A; Shim H
    Cancer Chemother Pharmacol; 2020 Feb; 85(2):413-423. PubMed ID: 31907648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying targets for the restoration and reactivation of BRM.
    Kahali B; Gramling SJ; Marquez SB; Thompson K; Lu L; Reisman D
    Oncogene; 2014 Jan; 33(5):653-64. PubMed ID: 23524580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers.
    Linares A; Assou S; Lapierre M; Thouennon E; Duraffourd C; Fromaget C; Boulahtouf A; Tian G; Ji J; Sahin O; Badia E; Boulle N; Cavaillès V
    Mol Oncol; 2019 Jul; 13(7):1534-1547. PubMed ID: 31099456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
    Raha P; Thomas S; Thurn KT; Park J; Munster PN
    Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression.
    Simpson NE; Tryndyak VP; Beland FA; Pogribny IP
    Breast Cancer Res Treat; 2012 Jun; 133(3):959-68. PubMed ID: 22101407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel histone deacetylase 8-selective inhibitor 1,3,4-oxadiazole-alanine hybrid induces apoptosis in breast cancer cells.
    Pidugu VR; Yarla NS; Bishayee A; Kalle AM; Satya AK
    Apoptosis; 2017 Nov; 22(11):1394-1403. PubMed ID: 28840369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability.
    Chao MW; Chu PC; Chuang HC; Shen FH; Chou CC; Hsu EC; Himmel LE; Huang HL; Tu HJ; Kulp SK; Teng CM; Chen CS
    Oncotarget; 2016 Jan; 7(2):1796-807. PubMed ID: 26625202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of HDAC9 as a viable therapeutic target for the treatment of gastric cancer.
    Xiong K; Zhang H; Du Y; Tian J; Ding S
    Exp Mol Med; 2019 Aug; 51(8):1-15. PubMed ID: 31451695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
    Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
    Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC8 Inhibition Blocks SMC3 Deacetylation and Delays Cell Cycle Progression without Affecting Cohesin-dependent Transcription in MCF7 Cancer Cells.
    Dasgupta T; Antony J; Braithwaite AW; Horsfield JA
    J Biol Chem; 2016 Jun; 291(24):12761-12770. PubMed ID: 27072133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Interaction of Class IIb Histone Deacetylase 6 (HDAC6) with Class IIa HDAC9 Controls Gonadotropin Releasing Hormone (GnRH) Neuronal Cell Survival and Movement.
    Salian-Mehta S; Xu M; McKinsey TA; Tobet S; Wierman ME
    J Biol Chem; 2015 May; 290(22):14045-56. PubMed ID: 25873389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
    Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
    Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of HDAC9 promotes oral squamous cell carcinoma growth, regulates cell cycle progression, and inhibits apoptosis.
    Rastogi B; Raut SK; Panda NK; Rattan V; Radotra BD; Khullar M
    Mol Cell Biochem; 2016 Apr; 415(1-2):183-96. PubMed ID: 26992905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways.
    Chen J; Li N; Liu B; Ling J; Yang W; Pang X; Li T
    Life Sci; 2020 May; 248():117469. PubMed ID: 32109485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
    Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
    Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer.
    Yang C; Croteau S; Hardy P
    Cell Oncol (Dordr); 2021 Oct; 44(5):997-1017. PubMed ID: 34318404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutual inhibition between HDAC9 and miR-17 regulates osteogenesis of human periodontal ligament stem cells in inflammatory conditions.
    Li L; Liu W; Wang H; Yang Q; Zhang L; Jin F; Jin Y
    Cell Death Dis; 2018 May; 9(5):480. PubMed ID: 29691366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells.
    Yu SL; Lee DC; Son JW; Park CG; Lee HY; Kang J
    Oncol Rep; 2013 Sep; 30(3):1293-300. PubMed ID: 23817620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-455-3p modulates cartilage development and degeneration through modification of histone H3 acetylation.
    Chen W; Chen L; Zhang Z; Meng F; Huang G; Sheng P; Zhang Z; Liao W
    Biochim Biophys Acta; 2016 Dec; 1863(12):2881-2891. PubMed ID: 27638301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.